Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ORKA
ORKA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ORKA News
VR Adviser, LLC Reduces Stake in Ocular Therapeutix
Mar 18 2026
Fool
VR Adviser, LLC Sells Shares of Ocular Therapeutix
Mar 18 2026
NASDAQ.COM
Experts Reveal Top Stock Picks with Doubling Potential
Mar 16 2026
NASDAQ.COM
VR Adviser Increases Stake in Savara by Over 1 Million Shares
Mar 15 2026
NASDAQ.COM
VR Adviser Increases Stake in Savara by Over 1 Million Shares
Mar 15 2026
Fool
Oruka Therapeutics Shares Hit 52-Week High Following Data Release Acceleration
Mar 13 2026
NASDAQ.COM
ORUKA THERAPEUTICS: BARCLAYS INCREASES TARGET PRICE TO $50, UP FROM $48
Mar 13 2026
moomoo
Oruka Therapeutics Reports Q4 Loss and Cash Position
Mar 12 2026
seekingalpha
Five Below Options Volume Hits 7,969 Contracts, 71.5% of Daily Average
Jan 09 2026
NASDAQ.COM
Oruka to Present Novel Biologics at 44th Annual J.P. Morgan Healthcare Conference
Jan 06 2026
Globenewswire
Sprott Silver Miners ETF Declines 2.3% with Americas Gold and Vizsla Silver Underperforming
Dec 31 2025
NASDAQ.COM
Gilead Sciences Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Thursday
Nov 13 2025
Benzinga
AutoZone Set to Surge Over 12%? Check Out 10 Leading Analyst Predictions for Thursday
Nov 13 2025
Benzinga
BTIG Reaffirms Buy Rating for Oruka Therapeutics and Increases Price Target to $63
Nov 13 2025
Benzinga
The Insider Report: Bulls Owe Their Success to Technology
Nov 02 2025
Benzinga
Guggenheim Begins Coverage of Oruka Therapeutics with a Buy Rating and Sets Price Target at $60
Oct 27 2025
Benzinga
Show More News
